These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 8958811
1. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. Matsuura R, Isaka N, Imanaka-Yoshida K, Yoshida T, Sakakura T, Nakano T. J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811 [Abstract] [Full Text] [Related]
2. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects]. Hombach V, Waltenberger J, Voisard R, Höher M. Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714 [Abstract] [Full Text] [Related]
3. [Cellularity and ultrastructural characteristics of human atherectomy specimens: comparison between restenosis and primary stenotic tissue of coronary and peripheral lesions]. Bauriedel G, Höfling B, Grünwaldt C, Beinert T, Welsch U. Z Kardiol; 1993 Aug; 82(8):485-93. PubMed ID: 8212782 [Abstract] [Full Text] [Related]
4. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty]. Holm AM, Haunsø S, Hansen PR. Ugeskr Laeger; 1998 Feb 23; 160(9):1302-6. PubMed ID: 9495077 [Abstract] [Full Text] [Related]
5. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. J Am Coll Cardiol; 1996 Nov 01; 28(5):1127-33. PubMed ID: 8890805 [Abstract] [Full Text] [Related]
6. [Current status of directional coronary atherectomy in interventional cardiology]. Höfling B, Gonschior P, Mack B, Gerheuser F, Bauriedel G, Nerlich A, Welsch U, Simpson JB. Z Kardiol; 1991 Nov 01; 80 Suppl 9():25-34. PubMed ID: 1796647 [Abstract] [Full Text] [Related]
7. Differences in histopathologic findings in restenotic lesions after directional coronary atherectomy or balloon angioplasty. Ono K, Imazu M, Ueda H, Hayashi Y, Shimamoto F, Yamakido M. Coron Artery Dis; 1998 Nov 01; 9(1):5-12. PubMed ID: 9589185 [Abstract] [Full Text] [Related]
8. [Is Palmaz-Schatz stenting effective for second restenosis?]. Kishi K, Hiasa Y, Suzuki N, Miyamoto H, Takahashi T, Hosokawa S, Tanimoto M, Otani R. J Cardiol; 1999 Nov 01; 34(5):243-8. PubMed ID: 10579132 [Abstract] [Full Text] [Related]
9. [Are directional coronary atherectomy and Palmaz-Schatz stent more efficacious than conventional balloon angioplasty for treating de novo coronary artery lesions?]. Nanasato M, Adachi M, Hirayama H, Tsuji Y, Yamada T, Yoshida Y, Yamada K, Miwata S, Tsuboi N, Itoh T, Maeda S, Kuriyama K. J Cardiol; 1997 Sep 01; 30(3):117-24. PubMed ID: 9309507 [Abstract] [Full Text] [Related]
10. [Restenosis after coronary angioplasty: its pathogenesis and prevention]. Marzocchi A, Marrozzini C, Piovaccari G, Fattori R, Castriota F, D'Anniballe G, Branzi A, Magnani B. Cardiologia; 1991 Dec 01; 36(12 Suppl 1):309-20. PubMed ID: 1841786 [Abstract] [Full Text] [Related]
11. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors]. Sakai Y, Tomobuchi Y, Hashizume T, Imanishi T, Tomimoto S, Toyoda Y, Arita M, Hano T, Nishio I. J Cardiol; 1997 Jan 01; 29(1):1-6. PubMed ID: 9023673 [Abstract] [Full Text] [Related]
12. [Preventive mechanisms and effects of pemirolast potassium on restenosis after percutaneous transluminal coronary angioplasty: serial coronary angiography and intravascular ultrasound studies]. Yoshinuma M. J Cardiol; 1999 Feb 01; 33(2):81-8. PubMed ID: 10087476 [Abstract] [Full Text] [Related]
13. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM). Asakura Y, Suzuki M, Nonogi H, Haze K, Sato A, Inada H, Okuda Y, Yamashita K, Harano Y. J Cardiovasc Risk; 1998 Feb 01; 5(5-6):331-4. PubMed ID: 9920005 [Abstract] [Full Text] [Related]
14. [Contribution of monocyte chemoattractant protein-1 and c-fms/macrophage colony-stimulating factor receptor to coronary artery disease: analysis of human coronary atherectomy specimens]. Iso Y, Suzuki H, Sato T, Shoji M, Shibata M, Hamazaki Y, Koba S, Sakai T, Murakami M, Geshi E, Katagiri T. J Cardiol; 2003 Jul 01; 42(1):29-36. PubMed ID: 12892039 [Abstract] [Full Text] [Related]
15. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression. Imanaka-Yoshida K, Matsuura R, Isaka N, Nakano T, Sakakura T, Yoshida T. Virchows Arch; 2001 Aug 01; 439(2):185-90. PubMed ID: 11561759 [Abstract] [Full Text] [Related]
16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M. J Physiol Pharmacol; 2001 Aug 01; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [Abstract] [Full Text] [Related]
17. [Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study]. Inoue K, Nakamura N, Kakio T, Suyama H, Tanaka S, Goto Y, Nakazawa Y, Yamamoto Y, Nagamatsu T. J Cardiol; 1994 Aug 01; 24(4):279-91. PubMed ID: 8057240 [Abstract] [Full Text] [Related]
18. The paradigm of restenosis following percutaneous transluminal coronary angioplasty. Preisack MB, Karsch KR. Eur Heart J; 1993 Nov 01; 14 Suppl I():187-92. PubMed ID: 8293774 [Abstract] [Full Text] [Related]